hydralazine and losartan

hydralazine has been researched along with losartan in 66 studies

Research

Studies (66)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's21 (31.82)18.2507
2000's28 (42.42)29.6817
2010's17 (25.76)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Andoh, TF; Bennett, WM; Burdmann, EA; Coffman, TM; Connors, BA; Evan, A; Lindsley, J; Nast, CC1
Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D1
Hajj-Ali, AF; Reilly, TM; Wong, PC1
Fukui, T; Horio, T; Kohno, M; Kurihara, N; Takeda, T; Yasunari, K; Yokokawa, K; Yoshiyama, M1
Brecher, P; Chobanian, AV; Crawford, DC; Himeno, H; Hosoi, M1
Soltis, EE1
Brink, M; Delafontaine, P; Wellen, J1
Frohlich, ED; Nuñez, E; Prakash, O; Susic, D1
Capers, Q; de Leon, H; Fukui, T; Griendling, KK; Harrison, DG; Ishizaka, N; Laursen, JB; Rajagopalan, S; Taylor, WR; Wilcox, JN1
Head, RJ; Irvine, RJ; White, JM1
Böhm, M; Flesch, M; Paul, M; Pinto, YM; Schnabel, P; Teisman, AC; van Gilst, WH; Zolk, O1
Chan, R; Irvine, RJ; White, J1
Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE1
Helmchen, U; Schneider, A; Stahl, RA; Wenzel, U; Wolf, G1
Böhm, M; Buikema, H; Flesch, M; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH1
Butcher, JW; Kasparov, S; Paton, JF1
Anderson, NH; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; Morton, JJ; Reid, JL; Schork, NJ1
Li, J; Wang, DH1
Ferrario, CM; Gallagher, PE; Ganten, D; Strawn, WB; Tallant, EA1
Dam, TV; deBlois, D; Hamet, P; Moreau, P; Tea, BS1
Cody, RJ; Goetze, S; Graf, K; Hsueh, WA; Kawano, H; Kawano, Y; Law, RE; Schnee, J1
Attias, J; Breslow, JL; Brodsky, S; Coleman, R; Hayek, T; Keidar, S; Smith, J1
Aizawa, T; Ingelfinger, JR; Ishizaka, N; Mori, I; Nagai, R; Ohno, M; Taguchi, Ji; Tang, SS1
Aizawa, T; Ishizaka, N; Mori, I; Nagai, R; Ohno, M; Taguchi, J; Yazaki, Y1
Esposito, G; Fox, JE; Hagaman, JR; Knowles, JW; Maeda, N; Mao, L; Rockman, HA; Smithies, O1
Abe, I; Kagiyama, S; Lin, Y; Matsumura, K; Tsuchihashi, T1
Adams, MA; Bushfield, TL; Hale, TM; Woolard, J1
Arens, T; Dendorfer, A; Dominiak, P; Häuser, W; Qadri, F; Schwarz, EC1
de Resende, MM; Gomes, Mda G; Leite, CM; Milanez, Mda C; Mill, JG1
Alonso, C; Catalán, MP; Egido, J; Gallego-Delgado, J; Gómez-Garre, D; Largo, R; Ortiz, A; Plaza, JJ; Soto, K; Tejera, N1
Amiri, F; Brassard, P; Schiffrin, EL1
Akiyama, S; Gessei-Tsutsumi, N; Goda, M; Hobara, N; Kawasaki, H; Kurosaki, Y; Takayama, F1
Bayraktutan, U; Demirci, B; McKeown, PP1
Amiri, F; Brassard, P; Schiffrin, EL; Thibault, G1
Adams, MA; Hale, TM; Hannan, JL; Heaton, JP; Smallegange, C1
Ayabe, N; Babaev, VR; Fazio, S; Fogo, AB; Ichikawa, I; Kon, V; Linton, MF; Ma, J; Suganuma, E; Zuo, Y1
Ishizaka, N; Matsuzaki, G; Mori, I; Nagai, R; Noiri, E; Saito, K1
Baumann, M; Hermans, JJ; Janssen, BJ; Peutz-Kootstra, C; Smits, JF; Struijker Boudier, HA; Witzke, O1
Agharazii, M; Larivière, R; Lebel, M; Rodrigue, ME1
Biswas, SK; de Faria, JB; de Faria, JM; Pinto, CC; Silva, KC; Souza, DS1
Ayabe, N; Babaev, VR; Fazio, S; Fogo, AB; Ichikawa, I; Kon, V; Linton, MF; Motojima, M; Suganuma, E; Zuo, Y1
Brezniceanu, ML; Chan, JS; Chénier, I; Filep, JG; Ingelfinger, JR; Liu, F; Sachetelli, S; Wei, CC; Zhang, SL1
Fujihara, CK; Machado, FG; Malheiros, DM; Mattar, AL; Zatz, R1
Cochain, C; Duriez, M; Lévy, BI; Loinard, C; Mees, B; Silvestre, JS; Vilar, J; You, D1
Amann, K; Hartner, A; Hilgers, KF; Klanke, B; Melk, A; Steinbach, MP; Westhoff, JH1
Bartholome, R; Baumann, M; Janssen, BJ; Rob Hermans, JJ; Smits, JF; Struijker Boudier, HA1
Agharazii, M; Bélanger, S; Larivière, R; Lebel, M; Lemieux, P; Therrien, F1
Chatziantoniou, C; Helle, F; Iversen, BM1
Casarini, DE; Coelho, MS; Ferreira, DN; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Rosa, KT1
Caruso-Neves, C; Landgraf, SS; Pinheiro, AA; Silva, JS; Sudo, RT; Takiya, CM; Wengert, M; Zapata-Sudo, G1
Alewijnse, AE; Chalfant, CE; De Mey, JG; Janssen, BJ; Meens, MJ; Nelissen, J; Peters, SL; Spijkers, LJ; Wijesinghe, D1
Ascione, R; Dominiczak, AF; Giannotta, M; Graham, D; Hendy, EB; Hewinson, J; Kasparov, S; Liu, B; McBride, F; Oliveira-Sales, EB; Paton, JF; Toward, M; Waki, H; Xu, H1
Cohen Tervaert, JW; Fazzi, GE; Heijnen, BF; Janssen, BJ; Mullins, JJ; Nelissen, J; Peutz-Kootstra, CJ; Schalkwijk, CG; Struijker-Boudier, HA; van Essen, H1
Hashimoto, T; Kitazato, KT; Kudo, M; Liang, EI; Makino, H; Murakami, S; Nagahiro, S; Shimada, K; Tada, Y; Wada, K1
Dopona, EP; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Pereira, RC; Shimizu, MH1
Chishaki, A; Hirooka, Y; Inoue, S; Kishi, T; Mukai, Y; Nagayama, T; Sunagawa, K; Takase, S; Takemoto, M1
Arruda-Junior, DF; Girardi, AC; Virgulino, SG1
Adhikari, S; Alpert, L; Bissonnette, M; Chen, L; Deb, DK; Dougherty, U; Hart, J; He, L; Kwon, J; Li, YC; Liu, SQ; Liu, T; Liu, W; Pekow, J; Rubin, DT; Shi, Y; Wang, J; Zhao, Q; Zhou, G1
De Mey, JG; Janssen, B; Lemkens, P; Meens, MJ; Nelissen, J; Peters, SL; Schiffers, PM; Spijkers, LJ1
Höcherl, K; Thurner, LR1

Reviews

1 review(s) available for hydralazine and losartan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

65 other study(ies) available for hydralazine and losartan

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril.
    The American journal of physiology, 1995, Volume: 269, Issue:4 Pt 2

    Topics: Animals; Biphenyl Compounds; Blood Pressure; Cyclosporine; Enalapril; Furosemide; Hydralazine; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles

1995
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    The American journal of physiology, 1994, Volume: 267, Issue:4 Pt 2

    Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic

1994
Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antibodies; Arginine; Biphenyl Compounds; Drug Interactions; Hemodynamics; Hydralazine; Imidazoles; Kidney; Losartan; Male; Nitroarginine; Prazosin; Rabbits; Tetrazoles; Vasoconstrictor Agents

1994
Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension.
    The American journal of physiology, 1994, Volume: 266, Issue:2 Pt 2

    Topics: Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Blood Urea Nitrogen; Cardiomegaly; Chromatography, High Pressure Liquid; Creatinine; Desoxycorticosterone; Enalapril; Heart; Hydralazine; Hypertension, Malignant; Imidazoles; Losartan; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred SHR; Sodium, Dietary; Tetrazoles

1994
Angiotensin II alters aortic fibronectin independently of hypertension.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:6 Pt 2

    Topics: Angiotensin II; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Fibronectins; Humans; Hydralazine; Hypertension; Imidazoles; Losartan; Male; Prazosin; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles

1994
Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Hydralazine; Hypertension; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Tetrazoles; Vasoconstriction

1993
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.
    The Journal of clinical investigation, 1996, Jun-01, Volume: 97, Issue:11

    Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Hematocrit; Hydralazine; Hypertension; Imidazoles; Infusions, Intravenous; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor I; Losartan; Male; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Reference Values; Tetrazoles; Time Factors; Vasodilator Agents; Weight Loss

1996
Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 28, Issue:2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Heart Ventricles; Hemodynamics; Hydralazine; Hypertrophy, Left Ventricular; Imidazoles; Infusion Pumps, Implantable; Losartan; Male; Myosin Heavy Chains; Organ Size; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles

1996
p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats.
    Circulation research, 1997, Volume: 80, Issue:1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Hydralazine; Imidazoles; In Situ Hybridization; Losartan; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase; Systole; Tetrazoles

1997
The renin angiotensin system and nociception in spontaneously hypertensive rats.
    Life sciences, 1995, Feb-17, Volume: 56, Issue:13

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Captopril; Hydralazine; Hypertension; Imidazoles; Losartan; Male; Motor Activity; Nociceptors; Pain Measurement; Pain Threshold; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles

1995
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    British journal of pharmacology, 1998, Volume: 123, Issue:3

    Topics: Adenylyl Cyclases; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; GTP-Binding Proteins; Hydralazine; Isoquinolines; Losartan; Myocardium; Neuropeptides; Organ Size; Quinapril; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Tetrahydroisoquinolines; Vasodilator Agents

1998
The influence of restraint on blood pressure in the rat.
    Journal of pharmacological and toxicological methods, 1997, Volume: 38, Issue:3

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Captopril; Heart Rate; Hydralazine; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Restraint, Physical; Telemetry

1997
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
    Kidney international, 1998, Volume: 53, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling

1998
Regulation of glomerular TGF-beta expression in the contralateral kidney of two-kidney, one-clip hypertensive rats.
    Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:5

    Topics: Animals; Antihypertensive Agents; Drug Combinations; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Kidney Glomerulus; Losartan; Male; Rats; Rats, Wistar; Reserpine; RNA, Messenger; Sclerosis; Time Factors; Transforming Growth Factor beta

1998
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
    Journal of hypertension, 1998, Volume: 16, Issue:12 Pt 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Heart Function Tests; Hydralazine; Hypertension; Isoquinolines; Losartan; Norepinephrine; Propanolamines; Quinapril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrahydroisoquinolines

1998
Angiotensin II receptors within the nucleus of the solitary tract mediate the developmental attenuation of the baroreceptor vagal reflex in pre-weaned rats.
    Journal of the autonomic nervous system, 1998, Dec-11, Volume: 74, Issue:2-3

    Topics: Age Factors; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Antihypertensive Agents; Blood Pressure; Halothane; Heart Rate; Hydralazine; Losartan; Male; Microinjections; Phenylephrine; Pressoreceptors; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reflex; Solitary Nucleus; Sympathomimetics; Urethane; Vagus Nerve; Weaning

1998
Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:1 Pt 2

    Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Cell Nucleus; Diastole; DNA; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Losartan; Lymphocytes; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Perindopril; Rats; Rats, Inbred SHR; Systole; Telemetry; Time Factors

1999
Antihypertensive mechanisms underlying a novel salt-sensitive hypertensive model induced by sensory denervation.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:1 Pt 2

    Topics: Animals; Animals, Newborn; Antihypertensive Agents; Blood Pressure; Body Weight; Calcitonin Gene-Related Peptide; Capsaicin; Diuresis; Ganglia, Spinal; Hydralazine; Hypertension; Losartan; Male; Nerve Degeneration; Neurons, Afferent; Potassium; Prazosin; Rats; Rats, Wistar; Sodium; Sodium, Dietary

1999
Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Cell Count; Blood Pressure; Cell Adhesion; Endothelium, Vascular; Female; Heart Rate; Hematocrit; Hydralazine; Hypertension; Losartan; Male; Monocytes; Nitroblue Tetrazolium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System

1999
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:2

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Cardiomegaly; Data Interpretation, Statistical; DNA; DNA Fragmentation; Enalapril; Hemodynamics; Hydralazine; Losartan; Male; Nifedipine; Propranolol; Rats; Time Factors

1999
Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: Actinin; Age Factors; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antigens, CD; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Collagen; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Heart Ventricles; Hydralazine; Imidazoles; Integrin alphaV; Integrin beta Chains; Integrin beta1; Integrin beta3; Integrins; Irbesartan; Laminin; Losartan; Myocardium; Phosphorylation; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Up-Regulation; Vitronectin

2000
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Cardiovascular research, 1999, Volume: 44, Issue:3

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Drug Administration Schedule; Fosinopril; Hydralazine; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Mice; Mice, Transgenic; Oxidation-Reduction; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2

1999
Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cell Line, Transformed; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glomerular Filtration Rate; Heart Rate; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hemin; Hydralazine; Hypertension; Immunohistochemistry; Kidney Tubules, Proximal; Losartan; Norepinephrine; Oxidative Stress; Proteinuria; Protoporphyrins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vasoconstrictor Agents; Vasodilator Agents

2000
Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cell Division; Gene Expression Regulation, Enzymologic; Heart; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hemodynamics; Hydralazine; Infusions, Intravenous; Kinetics; Losartan; Male; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic

2000
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
    The Journal of clinical investigation, 2001, Volume: 107, Issue:8

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Enalapril; Furosemide; Guanylate Cyclase; Hydralazine; Losartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Organ Size; Propranolol; Receptors, Atrial Natriuretic Factor; Telemetry; Ventricular Dysfunction, Left

2001
The influence of chronic antihypertensive treatment on the central pressor response in SHR.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2001, Volume: 24, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Brain; Enalapril; Epinephrine; Heart Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Injections, Intraventricular; Losartan; Male; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Saline Solution, Hypertonic; Tetrazoles

2001
Persistent lowering of arterial pressure after continuous and intermittent therapy.
    Journal of hypertension, 2003, Volume: 21, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Heart Rate; Heart Ventricles; Hydralazine; Hydrochlorothiazide; Hypertension; Losartan; Male; Nifedipine; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vasodilator Agents

2003
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension.
    Journal of hypertension, 2003, Volume: 21, Issue:9

    Topics: Age Factors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Brain; Enalapril; Hydralazine; Hypertension; Losartan; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Vasodilator Agents

2003
Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats.
    Clinical and experimental pharmacology & physiology, 2003, Volume: 30, Issue:10

    Topics: Animals; Cicatrix; Collagen; Hydralazine; Losartan; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Spironolactone

2003
Tight blood pressure control decreases apoptosis during renal damage.
    Kidney international, 2004, Volume: 65, Issue:3

    Topics: Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Cell Division; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Immunohistochemistry; Losartan; Male; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Tetrahydroisoquinolines

2004
Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:3

    Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blotting, Western; Collagen Type I; Elasticity; Elastin; Fibronectins; Hydralazine; Losartan; Male; Matrix Metalloproteinase 2; Mesenteric Artery, Superior; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Resistance

2005
Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:5

    Topics: Aging; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcitonin Gene-Related Peptide; Cell Count; Hydralazine; Hypertension; Immunohistochemistry; Losartan; Male; Mesenteric Arteries; Nerve Fibers; Neuropeptide Y; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Sympathetic Nervous System; Thiazepines; Vasodilator Agents

2005
Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
    Journal of hypertension, 2005, Volume: 23, Issue:12

    Topics: Aging; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Coronary Vessels; Hydralazine; Hydrochlorothiazide; Hypertension; In Vitro Techniques; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride Symporter Inhibitors; Vasodilation; Vasodilator Agents

2005
Role of angiotensin type-1 and angiotensin type-2 receptors in the expression of vascular integrins in angiotensin II-infused rats.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 47, Issue:1

    Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Vessels; Hydralazine; Hypertension; Infusion Pumps; Integrins; Losartan; Male; Osteopontin; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sialoglycoproteins; Vasoconstrictor Agents; Vasodilator Agents

2006
Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats.
    Journal of hypertension, 2006, Volume: 24, Issue:1

    Topics: Aging; Animals; Antihypertensive Agents; Apomorphine; Blood Pressure; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Transplantation; Losartan; Male; Nifedipine; Penile Erection; Random Allocation; Rats; Rats, Inbred SHR; Testosterone

2006
Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atherosclerosis; Cholesterol; Creatinine; Disease Models, Animal; Female; Hydralazine; Losartan; Mice; Mice, Inbred C57BL; Nephrectomy; Renal Insufficiency

2006
Expression and localization of PDGF-B, PDGF-D, and PDGF receptor in the kidney of angiotensin II-infused rat.
    Laboratory investigation; a journal of technical methods and pathology, 2006, Volume: 86, Issue:12

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Cell Proliferation; Gene Expression Regulation; Hydralazine; In Situ Hybridization; Iron; Kidney; Lipid Metabolism; Losartan; Lymphokines; Male; Norepinephrine; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; Vasoconstrictor Agents

2006
Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
    Journal of hypertension, 2007, Volume: 25, Issue:1

    Topics: Age Factors; Aging; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Heart Ventricles; Hydralazine; Hypertension; Kidney; Losartan; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasodilator Agents; Ventricular Function, Left

2007
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    American journal of hypertension, 2006, Volume: 19, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney; Kidney Failure, Chronic; Losartan; Nephrectomy; Rats; Rats, Wistar; Recombinant Proteins; Renin-Angiotensin System; Reserpine; Time Factors; Uremia

2006
Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats.
    Experimental eye research, 2007, Volume: 85, Issue:1

    Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Diabetic Retinopathy; Drug Combinations; Eye Proteins; Hydralazine; Hydrochlorothiazide; Hypertension; Immunohistochemistry; Intercellular Adhesion Molecule-1; Losartan; Male; Microglia; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Retina; Transcription Factor RelA

2007
Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.
    Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:8

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Disease Progression; Elasticity; Female; Hydralazine; Lipids; Losartan; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Vasoconstrictor Agents

2007
Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
    Journal of the American Society of Nephrology : JASN, 2008, Volume: 19, Issue:2

    Topics: Albuminuria; Angiotensinogen; Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blood Glucose; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hydralazine; Hypertension, Renal; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Rats; Renin-Angiotensin System

2008
Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.
    Clinics (Sao Paulo, Brazil), 2007, Volume: 62, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Hydralazine; Hypertension; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Losartan; Male; Mycophenolic Acid; Nitric Oxide; Rats; Rats, Wistar; Sodium Chloride, Dietary

2007
Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Cells; Cell Differentiation; Disease Models, Animal; Endothelium, Vascular; Hindlimb; Hydralazine; Hypertension; Ischemia; Ligation; Losartan; Male; Neovascularization, Physiologic; Oxidative Stress; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stem Cells

2008
Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Desoxycorticosterone; Heart Ventricles; Humans; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Kidney; Losartan; Mice; Mineralocorticoid Receptor Antagonists; Nephrosclerosis; p38 Mitogen-Activated Protein Kinases; Rats; Renin; Reserpine; RNA, Messenger; Spironolactone

2008
Renal medullary effects of transient prehypertensive treatment in young spontaneously hypertensive rats.
    Acta physiologica (Oxford, England), 2009, Volume: 196, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Cysteine Proteinase Inhibitors; Drug Therapy, Combination; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hydralazine; Hypertension; Kidney Medulla; Losartan; Male; Oligopeptides; Osmolar Concentration; Pericytes; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sodium; Urine; Valproic Acid

2009
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
    European journal of pharmacology, 2009, Apr-01, Volume: 607, Issue:1-3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Endothelin-1; Hydralazine; Hypertension, Malignant; Losartan; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency

2009
Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Disease Models, Animal; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Kidney; Kidney Diseases; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Vasoconstriction

2010
Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in Wistar rats.
    The Journal of nutrition, 2010, Volume: 140, Issue:10

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Disease Models, Animal; Drinking; Eating; Echocardiography; Fibrosis; Gene Expression; Heart Ventricles; Hydralazine; Hypertension; Losartan; Male; Myocardium; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Transforming Growth Factor beta; Urine

2010
Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats.
    American journal of physiology. Renal physiology, 2011, Volume: 300, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Collagen; Cyclic AMP-Dependent Protein Kinases; Gene Expression; Hydralazine; Hypertension; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Losartan; Macrophages; Male; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System

2011
Antihypertensive treatment differentially affects vascular sphingolipid biology in spontaneously hypertensive rats.
    PloS one, 2011, Volume: 6, Issue:12

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Blood Vessels; Carotid Arteries; Ceramides; Endothelium, Vascular; Group VI Phospholipases A2; Hydralazine; In Vitro Techniques; Losartan; Male; Rats; Rats, Inbred SHR; Sphingolipids; Sphingomyelin Phosphodiesterase; Vasoconstriction

2011
Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension.
    Cardiovascular research, 2012, Dec-01, Volume: 96, Issue:3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterial Pressure; Biomarkers; Blood Vessels; Case-Control Studies; Cell Adhesion Molecules; Cell Line; Disease Models, Animal; Humans; Hydralazine; Hypertension; Hypertension, Renovascular; Losartan; Male; Morpholinos; Prehypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Cell Surface; RNA, Messenger; Time Factors; Up-Regulation; Vasodilator Agents

2012
Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Animals; Biomarkers; Hemodynamics; Hydralazine; Hypertension; Kidney; Losartan; Rats; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; T-Lymphocytes; Time Factors

2013
Roles of hypertension in the rupture of intracranial aneurysms.
    Stroke, 2014, Volume: 45, Issue:2

    Topics: Aneurysm, Ruptured; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Desoxycorticosterone Acetate; Dose-Response Relationship, Drug; Hydralazine; Hypertension; Intracranial Aneurysm; Losartan; Male; Mice; Mice, Inbred C57BL; Pancreatic Elastase; Renin-Angiotensin System; Risk Factors; Subarachnoid Hemorrhage; Survival Analysis; Treatment Outcome

2014
High-salt intake induces cardiomyocyte hypertrophy in rats in response to local angiotensin II type 1 receptor activation.
    The Journal of nutrition, 2014, Volume: 144, Issue:10

    Topics: Acetylcysteine; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hematocrit; Hydralazine; Losartan; Male; Myocytes, Cardiac; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Thiobarbituric Acid Reactive Substances

2014
Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
    American journal of hypertension, 2015, Volume: 28, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Biomarkers; Blood Pressure; Brain; Disease Models, Animal; Echocardiography; Electrocardiography; Hydralazine; Hypertension; Infusions, Intraventricular; Losartan; Male; Norepinephrine; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Sympathetic Nervous System; Time Factors

2015
Reduced tubular proteinuria in hypertensive rats treated with losartan is associated with higher renal cortical megalin expression.
    Hormone molecular biology and clinical investigation, 2014, Volume: 18, Issue:2

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Glomerular Filtration Barrier; Hydralazine; Kidney Cortex; Losartan; Low Density Lipoprotein Receptor-Related Protein-2; Male; Proteinuria; Rats, Inbred SHR; Receptors, Cell Surface

2014
Activation of the Renin-Angiotensin System Promotes Colitis Development.
    Scientific reports, 2016, 06-08, Volume: 6

    Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Colitis; Colon; Epithelial Cells; Fumarates; Humans; Hydralazine; Inflammatory Bowel Diseases; Losartan; Mice; Mice, Transgenic; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Th17 Cells

2016
Dual NEP/ECE inhibition improves endothelial function in mesenteric resistance arteries of 32-week-old SHR.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2017, Volume: 40, Issue:8

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzazepines; Bosentan; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Hypertension; Losartan; Mesenteric Arteries; Muscle Contraction; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Protease Inhibitors; Rats; Rats, Inbred SHR; Sulfonamides; Vascular Resistance

2017
Role of protease-activated receptor 2 in regulation of renin synthesis and secretion in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:11

    Topics: Animals; Dose-Response Relationship, Drug; Furosemide; Gene Expression; Hydralazine; Isoproterenol; Kidney; Lipopolysaccharides; Losartan; Male; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Receptor, PAR-2; Renin; Sodium Chloride

2019
chemdatabank.com